[Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca]
- PMID: 12506265
[Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca]
Abstract
Menstruation is a biological phenomenon that has been subject of myths and taboos within and among various cultures. These myths distort the reality surrounding menstruation and create ambivalent feelings about the value and usefulness of this function outside of its necessity as mean of reproduction. Thus studies concerning menstruation need to take into account cultural and psychosocial factors that define the meaning, values and behavior associated with this biological phenomenon. According to several studies, 70% of women experience psychological faintness during this menstrual phase, 40% of them have these symptoms at each menstruation and between 3 to 8% of them suffer severely reacquiring medical support. This entity called premenstrual dysphoric disorder is defined by the presence of several symptoms (distress, tension, irritability, moodiness.) with a significant impairment in work or social functioning beginning during the week before and ending within a few days after the onset of menses. Several studies conducted over the past few years suggested that selective serotonin reuptake inhibitors (SSRIs) and serotoninergic tricyclic drugs may be more effective than other types of antidepressants in treating PMS symptoms. Two protocols are proposed; a continuous treatment or intermittent use during few days during pre-menstrual and menstrual phase for several cycles. The objective of the current study was to evaluate the prevalence of a potential premenstrual dysphoric disorder (PMDD) during one menstrual cycle, in a representative sample of general population of Casablanca, according the DSM IV criteria. On the other hand, a questionnaire, available from the authors, was used to explore socio-demographic data. Among 618 women interviewed, 310 met the criteria of a potential PMDD (50.2%). The mean age of the population with PMDD was 32.2 8 years ranging from 20 to 50 years; 54.8% of them were married, 33.9% of them were single and 66.5% of them had between 1 to 4 children. Two third of them were without a professional activity. During this premenstrual phase the following symptoms were found among the whole sample: marked depressive mood, feeling of hopelessness, or self-depreciation thoughts (77.7%, n=241%); difficulty of concentration (65%, n=201); marked change in appetite, overeating or specific food craving (82.8%, n=256); marked affective lability, with sadness tearful and increased sensitivity to rejection (65.8%, n=204); hypersomnia or insomnia (59.7%, n=185); subjective sense of being overwhelmed or out of control (55.7%, n=172); lethargy, excessive fatigability (91.6%, n=283); physical symptoms including breast tenderness, swelling, headache, joint or muscular pain, and a sensation of bloating and weight gain (81.9%, n=253). The most severe symptoms were fatigue and irritability. On the other hand, 73.9% of the sample had a disturbance in their socio-professional lives as a consequence to the psychological disturbances. Half of these women consulted a physician, mostly a general practitioner. These data are in accordance with the literature, confirming that this disorder is common and has a bad impact on mental health and on quality of life of the women suffering from PMDD.
Similar articles
-
Premenstrual Dysphoric Disorder.2023 Feb 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Feb 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30335340 Free Books & Documents.
-
[Psychiatric and psychological aspects of premenstrual syndrome].Encephale. 2001 Nov-Dec;27(6):501-8. Encephale. 2001. PMID: 11865558 Review. French.
-
[Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].Encephale. 2024 Apr;50(2):211-232. doi: 10.1016/j.encep.2023.08.007. Epub 2023 Oct 9. Encephale. 2024. PMID: 37821319 Review. French.
-
The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.BMJ Case Rep. 2023 Dec 30;16(12):e258343. doi: 10.1136/bcr-2023-258343. BMJ Case Rep. 2023. PMID: 38160030
-
[Premenstrual syndrome and premenstrual dysphoric disorder].Orv Hetil. 2022 Jun 26;163(26):1023-1031. doi: 10.1556/650.2022.32496. Print 2022 Jun 26. Orv Hetil. 2022. PMID: 35895486 Hungarian.
Cited by
-
Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study.Nutr J. 2005 Feb 9;4:6. doi: 10.1186/1475-2891-4-6. Nutr J. 2005. PMID: 15703073 Free PMC article.
-
Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.J Womens Health (Larchmt). 2009 Jan-Feb;18(1):31-9. doi: 10.1089/jwh.2008.0932. J Womens Health (Larchmt). 2009. PMID: 19105683 Free PMC article.
-
Prevalence, phenomenology and personality characteristics of premenstrual dysphoric disorder among female students at Zagazig University, Egypt.Afr J Prim Health Care Fam Med. 2021 Aug 30;13(1):e1-e9. doi: 10.4102/phcfm.v13i1.2924. Afr J Prim Health Care Fam Med. 2021. PMID: 34476974 Free PMC article.
-
Toxoplasma gondii Infection and Premenstrual Dysphoric Disorder: A Cross-Sectional Study.J Clin Med Res. 2016 Oct;8(10):730-6. doi: 10.14740/jocmr2699w. Epub 2016 Aug 30. J Clin Med Res. 2016. PMID: 27635178 Free PMC article.
-
The influence of early life sexual abuse on oxytocin concentrations and premenstrual symptomatology in women with a menstrually related mood disorder.Biol Psychol. 2015 Jul;109:1-9. doi: 10.1016/j.biopsycho.2015.04.003. Epub 2015 Apr 17. Biol Psychol. 2015. PMID: 25892085 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous